Jennifer Tursi

4.3k citations
25 papers · 3.2k indexed · 1 hit paper · h-index 14
Topics
Colorectal Cancer Treatments and Studies (10 papers)Lung Cancer Treatments and Mutations (7 papers)Gastric Cancer Management and Outcomes (6 papers)

In The Last Decade

Jennifer Tursi

24 papers receiving 3.1k citations

Hit Papers

First-Line Crizotinib versus Chemotherapy in ALK-Positive...2014202620182022201450010001.5k2.0k

Peers

Jennifer Tursi
Comparison fields: 5 of 88
  • Pulmonary and Respiratory Medicine 2.5k
  • Oncology 2.1k
  • Molecular Biology 841
  • Cancer Research 681
  • Pathology and Forensic Medicine 299
Replace Robert M. Jotte with:
Robert M. Jotte United States
Susan Ellard Canada
Giovanni Selvaggi Italy
Janice M. Mehnert United States
Martin Sebastian Germany
Alan Anthoney United Kingdom
Sameek Roychowdhury United States
Katherine Liau United States
Anna Spreafico Canada
Roland E. Knoblauch United States
Jennifer Tursi relative to Robert M. Jotte United States Robert M. Jotte's profile →
Citations per field
00.5×2.9×
Robert M. Jotte · 1×
Citations per year

Countries citing papers authored by Jennifer Tursi

Since Specialization
Citations

This map shows the geographic impact of Jennifer Tursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Tursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Tursi more than expected).

Fields of papers citing papers by Jennifer Tursi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Tursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Tursi. The network helps show where Jennifer Tursi may publish in the future.

Co-authorship network of co-authors of Jennifer Tursi

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Tursi. A scholar is included among the top collaborators of Jennifer Tursi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Tursi. Jennifer Tursi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 29
3 10
4 191
5
Intracranial efficacy of first-line crizotinib vs. chemotherapy in ALK-positive NSCLC
1
6
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancerbreakdown →
2327
7 2
8 53
9 10
10 15
11
ASSOCIATIONS BETWEEN GERMLINE GENOTYPE AND EFFICACY AND SAFETY OUTCOMES IN A PHASE III STUDY OF SUNITINIB AND FOLFIRI IN METASTATIC COLORECTAL CANCER (MCRC)
1
12 21
13 153
14 3
15 2
16 31
17 24
18 48
19 12
20 90

About Jennifer Tursi

Jennifer Tursi is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 3.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.5k citations), Oncology (2.1k citations) and Cancer Research (681 citations). Jennifer Tursi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Enriqueta Felip, Tony Mok, Benjamin Solomon, Jolanda Paolini, Yi‐Long Wu, Tarek Mekhail, Tiziana Usari, Fiona Blackhall, Federico Cappuzzo and Kazuhiko Nakagawa. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026